Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 52

1.

Bortezomib-based induction for transplant ineligible AL amyloidosis and feasibility of later transplantation.

Cornell RF, Zhong X, Arce-Lara C, Atallah E, Blust L, Drobyski WR, Fenske TS, Pasquini MC, Rizzo JD, Saber W, Hari PN.

Bone Marrow Transplant. 2015 Jul;50(7):914-7. doi: 10.1038/bmt.2015.73. Epub 2015 Apr 27.

PMID:
25915809
2.

Prospective Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index: A Center for International Blood and Marrow Transplant Research Study.

Sorror ML, Logan BR, Zhu X, Rizzo JD, Cooke KR, McCarthy PL, Ho VT, Horowitz MM, Pasquini MC.

Biol Blood Marrow Transplant. 2015 Aug;21(8):1479-87. doi: 10.1016/j.bbmt.2015.04.004. Epub 2015 Apr 7.

PMID:
25862591
3.

The Sequence of Cyclophosphamide and Myeloablative Total Body Irradiation in Hematopoietic Cell Transplantation for Patients with Acute Leukemia.

Holter-Chakrabarty JL, Pierson N, Zhang MJ, Zhu X, Akpek G, Aljurf MD, Artz AS, Baron F, Bredeson CN, Dvorak CC, Epstein RB, Lazarus HM, Olsson RF, Selby GB, Williams KM, Cooke KR, Pasquini MC, McCarthy PL.

Biol Blood Marrow Transplant. 2015 Jul;21(7):1251-7. doi: 10.1016/j.bbmt.2015.03.017. Epub 2015 Mar 31.

PMID:
25840335
4.

Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies.

Olsson RF, Logan BR, Chaudhury S, Zhu X, Akpek G, Bolwell BJ, Bredeson CN, Dvorak CC, Gupta V, Ho VT, Lazarus HM, Marks DI, Ringdén OT, Pasquini MC, Schriber JR, Cooke KR.

Leukemia. 2015 Mar 16. doi: 10.1038/leu.2015.75. [Epub ahead of print]

PMID:
25772027
5.

Five hematologic tests and treatments to question.

Hicks LK, Bering H, Carson KR, Haynes AE, Kleinerman J, Kukreti V, Ma A, Mueller BU, O'Brien SH, Panepinto JA, Pasquini MC, Rajasekhar A, Sarode R, Wood WA.

Hematology Am Soc Hematol Educ Program. 2014 Dec 5;2014(1):599-603. doi: 10.1182/asheducation-2014.1.599. Epub 2014 Nov 18.

PMID:
25696917
6.

Impact of conditioning regimen on outcomes for patients with lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation.

Chen YB, Lane AA, Logan BR, Zhu X, Akpek G, Aljurf MD, Artz AS, Bredeson CN, Cooke KR, Ho VT, Lazarus HM, Olsson RF, Saber W, McCarthy PL, Pasquini MC.

Biol Blood Marrow Transplant. 2015 Jun;21(6):1046-53. doi: 10.1016/j.bbmt.2015.02.005. Epub 2015 Feb 14.

PMID:
25687795
7.

Five hematologic tests and treatments to question.

Hicks LK, Bering H, Carson KR, Haynes AE, Kleinerman J, Kukreti V, Ma A, Mueller BU, O'Brien SH, Panepinto JA, Pasquini MC, Rajasekhar A, Sarode R, Wood WA.

Blood. 2014 Dec 4;124(24):3524-8. doi: 10.1182/blood-2014-09-599399.

PMID:
25472968
8.

Comparison of non-myeloablative conditioning regimens for lymphoproliferative disorders.

Hong S, Le-Rademacher J, Artz A, McCarthy PL, Logan BR, Pasquini MC.

Bone Marrow Transplant. 2015 Mar;50(3):367-74. doi: 10.1038/bmt.2014.269. Epub 2014 Dec 1.

PMID:
25437248
9.

Recommendations for donor human leukocyte antigen assessment and matching for allogeneic stem cell transplantation: consensus opinion of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN).

Howard CA, Fernandez-Vina MA, Appelbaum FR, Confer DL, Devine SM, Horowitz MM, Mendizabal A, Laport GG, Pasquini MC, Spellman SR.

Biol Blood Marrow Transplant. 2015 Jan;21(1):4-7. doi: 10.1016/j.bbmt.2014.09.017. Epub 2014 Sep 30.

PMID:
25278457
10.

Phase 3 clinical trial of steroids/mycophenolate mofetil vs steroids/placebo as therapy for acute GVHD: BMT CTN 0802.

Bolaños-Meade J, Logan BR, Alousi AM, Antin JH, Barowski K, Carter SL, Goldstein SC, Hexner EO, Horowitz MM, Lee SJ, Levine JE, MacMillan ML, Martin PJ, Mendizabal AM, Nakamura R, Pasquini MC, Weisdorf DJ, Westervelt P, Ho VT.

Blood. 2014 Nov 20;124(22):3221-7; quiz 3335. doi: 10.1182/blood-2014-06-577023. Epub 2014 Aug 28.

PMID:
25170121
11.

Challenges and opportunities for HSCT outcome registries: perspective from international HSCT registries experts.

Aljurf M, Rizzo JD, Mohty M, Hussain F, Madrigal A, Pasquini MC, Passweg J, Chaudhri N, Ghavamzadeh A, Solh HE, Atsuta Y, Szer J, Kodera Y, Niederweiser D, Gratwohl A, Horowitz MM.

Bone Marrow Transplant. 2014 Aug;49(8):1016-21. doi: 10.1038/bmt.2014.78. Epub 2014 Apr 28. Review.

PMID:
24777183
12.

Allogeneic hematopoietic cell transplant for acute myeloid leukemia: Current state in 2013 and future directions.

Kanate AS, Pasquini MC, Hari PN, Hamadani M.

World J Stem Cells. 2014 Apr 26;6(2):69-81. doi: 10.4252/wjsc.v6.i2.69. Review.

13.

Lenalidomide maintenance for high-risk multiple myeloma after allogeneic hematopoietic cell transplantation.

Alsina M, Becker PS, Zhong X, Adams A, Hari P, Rowley S, Stadtmauer EA, Vesole DH, Logan B, Weisdorf D, Qazilbash M, Popplewell LL, McClune B, Bensinger W, Riches M, Giralt SA, Pasquini MC; Resource for Clinical Investigation in Blood and Marrow Transplantation.

Biol Blood Marrow Transplant. 2014 Aug;20(8):1183-9. doi: 10.1016/j.bbmt.2014.04.014. Epub 2014 Apr 21.

PMID:
24769014
14.

Effect of body mass in children with hematologic malignancies undergoing allogeneic bone marrow transplantation.

Aplenc R, Zhang MJ, Sung L, Zhu X, Ho VT, Cooke K, Dvorak C, Hale G, Isola LM, Lazarus HM, McCarthy PL, Olsson R, Pulsipher M, Pasquini MC, Bunin N; Regimen-Related Toxicity Working Committee, Center for International Blood and Marrow Transplant Research.

Blood. 2014 May 29;123(22):3504-11. doi: 10.1182/blood-2013-03-490334. Epub 2014 Apr 7.

15.

Hematopoietic cell transplant comorbidity index is predictive of survival after autologous hematopoietic cell transplantation in multiple myeloma.

Saad A, Mahindra A, Zhang MJ, Zhong X, Costa LJ, Dispenzieri A, Drobyski WR, Freytes CO, Gale RP, Gasparetto CJ, Holmberg LA, Kamble RT, Krishnan AY, Kyle RA, Marks D, Nishihori T, Pasquini MC, Ramanathan M, Lonial S, Savani BN, Saber W, Sharma M, Sorror ML, Wirk BM, Hari PN.

Biol Blood Marrow Transplant. 2014 Mar;20(3):402-408.e1. doi: 10.1016/j.bbmt.2013.12.557. Epub 2013 Dec 14.

16.

Prospective cohort study comparing intravenous busulfan to total body irradiation in hematopoietic cell transplantation.

Bredeson C, LeRademacher J, Kato K, Dipersio JF, Agura E, Devine SM, Appelbaum FR, Tomblyn MR, Laport GG, Zhu X, McCarthy PL, Ho VT, Cooke KR, Armstrong E, Smith A, Rizzo JD, Burkart JM, Pasquini MC.

Blood. 2013 Dec 5;122(24):3871-8. doi: 10.1182/blood-2013-08-519009. Epub 2013 Sep 30.

17.

Divergent effects of novel immunomodulatory agents and cyclophosphamide on the risk of engraftment syndrome after autologous peripheral blood stem cell transplantation for multiple myeloma.

Cornell RF, Hari P, Zhang MJ, Zhong X, Thompson J, Fenske TS, Horowitz MM, Komorowski R, Palmer J, Pasquini MC, Rizzo JD, Saber W, Thomas M, Drobyski WR.

Biol Blood Marrow Transplant. 2013 Sep;19(9):1368-73. doi: 10.1016/j.bbmt.2013.06.017. Epub 2013 Jun 24.

18.

Anatomy of a successful practice-changing study: a Blood and Marrow Transplantation Clinical Trials Network-National Cancer Institute Cooperative Group collaboration.

Giralt S, McCarthy PL, Anderson KC, Carter SL, Richardson PG, Rajkumar SV, Laport GG, Stadtmauer EA, Pasquini MC, Horowitz MM.

Biol Blood Marrow Transplant. 2013 Jun;19(6):858-9. doi: 10.1016/j.bbmt.2013.03.015. Epub 2013 Mar 29. No abstract available.

19.

Quantitative and qualitative differences in use and trends of hematopoietic stem cell transplantation: a Global Observational Study.

Gratwohl A, Baldomero H, Gratwohl M, Aljurf M, Bouzas LF, Horowitz M, Kodera Y, Lipton J, Iida M, Pasquini MC, Passweg J, Szer J, Madrigal A, Frauendorfer K, Niederwieser D; Worldwide Network of Blood and Marrow Transplantation (WBMT).

Haematologica. 2013 Aug;98(8):1282-90. doi: 10.3324/haematol.2012.076349. Epub 2013 Mar 18.

20.

Effects of spleen status on early outcomes after hematopoietic cell transplantation.

Akpek G, Pasquini MC, Logan B, Agovi MA, Lazarus HM, Marks DI, Bornhaeüser M, Ringdén O, Maziarz RT, Gupta V, Popat U, Maharaj D, Bolwell BJ, Rizzo JD, Ballen KK, Cooke KR, McCarthy PL, Ho VT.

Bone Marrow Transplant. 2013 Jun;48(6):825-31. doi: 10.1038/bmt.2012.249. Epub 2012 Dec 10.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk